U.S. RESEARCH ROUNDUP-Expedia Group, Hasbro, Palisade Bio

Reuters
2025/12/29
U.S. RESEARCH ROUNDUP-<a href="https://laohu8.com/S/EXPE">Expedia</a> Group, Hasbro, <a href="https://laohu8.com/S/PALI">Palisade Bio</a>

Dec 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Expedia Group, Hasbro and Palisade Bio on Monday.

HIGHLIGHTS

* Expedia Group Inc EXPE.O: Argus Research raises target price to $340 from $300

* Hasbro Inc HAS.O: Jefferies raises target price to $95 from $90

* Palisade Bio Inc PALI.O: Piper Sandler initiates coverage with overweight rating

* Praxis Precision Medicines Inc PRAX.O: BTIG raises target price to $843 from $507

* Vail Resorts Inc MTN.N: Truist Securities cuts target price to $234 from $237

Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.

* Amicus Therapeutics Inc FOLD.O: Leerink Partners cuts target price to $14.50 from $17

* Amicus Therapeutics Inc FOLD.O: Leerink Partners cuts to market perform from outperform

* BP BP.N: Gerdes Energy Research cuts target price by $1 to $48

* Citigroup C.N: Piper Sandler raises target price to $130 from $120

* Expedia Group Inc EXPE.O: Argus Research raises target price to $340 from $300

* Hasbro Inc HAS.O: Jefferies raises target price to $95 from $90

* Palisade Bio Inc PALI.O: Piper Sandler initiates coverage with overweight rating

* Palisade Bio Inc PALI.O: Piper Sandler initiates coverage with price target $25

* Praxis Precision Medicines Inc PRAX.O: BTIG raises target price to $843 from $507

* Vail Resorts Inc MTN.N: Truist Securities cuts target price to $234 from $237

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10